blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1140141

EP1140141 - METHODS FOR TREATING CANCER AND FOR MEDIATING CHEMOTAXIS OF DENDRITIC CELLS [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  15.10.2004
Database last updated on 05.07.2024
Most recent event   Tooltip15.10.2004Refusal of applicationpublished on 01.12.2004  [2004/49]
Applicant(s)For all designated states
CHIRON CORPORATION
4560 Horton Street
Emeryville CA 94608-2916 / US
[N/P]
Former [2001/41]For all designated states
CHIRON CORPORATION
4560 Horton Street
Emeryville, California 94608 / US
Inventor(s)01 / CHU, Keting
4560 Horton Street
Emeryville, CA 94608 / US
02 / XIN, Hong
3105 6400 Christie Avenue
La Jolla, CA 92037 / US
03 / CHAN, Vivien, W., F.
4560 Horton Street
Emeryville, CA 94608 / US
04 / KOTHAKOTA, Srinivas
932 7th Street, Apt.10
Santa Monica, CA 90403 / US
05 / WILLIAMS, Lewis, T.
3 Miraflores
Tiburon, CA 94920 / US
06 / WINTER, Jill, A.
435 Mount Street
Richmond, CA 94805 / US
 [2001/41]
Representative(s)Hallybone, Huw George
Carpmaels & Ransford LLP
One Southampton Row
London WC1B 5HA / GB
[N/P]
Former [2002/48]Hallybone, Huw George
Carpmaels and Ransford, 43 Bloomsbury Square
London WC1A 2RA / GB
Former [2001/41]Irvine, Jonquil Claire
J.A. KEMP & CO. 14 South Square Gray's Inn
London WC1R 5JJ / GB
Application number, filing date99968968.028.12.1999
[2001/41]
WO1999US31096
Priority number, dateUS19980114498P31.12.1998         Original published format: US 114498 P
[2001/41]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO0038706
Date:06.07.2000
Language:EN
[2000/27]
Type: A2 Application without search report 
No.:EP1140141
Date:10.10.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 06.07.2000 takes the place of the publication of the European patent application.
[2001/41]
Search report(s)International search report - published on:EP23.11.2000
ClassificationIPC:A61K38/19, A61K48/00, A61P35/00, // A61K38:19, A61K38:20
[2001/41]
CPC:
A61K38/195 (EP); A61K38/2013 (EP); A61P35/00 (EP);
A61P37/00 (EP); A61P43/00 (EP)
C-Set:
A61K38/195, A61K2300/00 (EP);
A61K38/2013, A61K2300/00 (EP)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/41]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON KREBS UND VERMITTLUNG VON DENDRITISCHEN ZELLENCHEMOTAXIS[2001/41]
English:METHODS FOR TREATING CANCER AND FOR MEDIATING CHEMOTAXIS OF DENDRITIC CELLS[2001/41]
French:METHODES DE TRAITEMENT DU CANCER ET DE MEDIATION DE LA CHIMIOTAXIE DES CELLULES DENDRITIQUES[2001/41]
Entry into regional phase19.07.2001National basic fee paid 
19.07.2001Designation fee(s) paid 
19.07.2001Examination fee paid 
Examination procedure25.07.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
19.07.2001Examination requested  [2001/41]
09.10.2001Despatch of a communication from the examining division (Time limit: M06)
17.04.2002Reply to a communication from the examining division
03.06.2002Despatch of a communication from the examining division (Time limit: M06)
12.12.2002Reply to a communication from the examining division
17.04.2003Despatch of a communication from the examining division (Time limit: M06)
27.10.2003Reply to a communication from the examining division
07.05.2004Despatch of a communication from the examining division (Time limit: M02)
21.05.2004Reply to a communication from the examining division
01.07.2004Despatch of communication that the application is refused, reason: substantive examination [2004/49]
11.07.2004Application refused, date of legal effect [2004/49]
Fees paidRenewal fee
19.07.2001Renewal fee patent year 03
23.12.2002Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.12.200305   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9831809  ;
 [X]WO9606169  (HUMAN GENOME SCIENCES INC ;LI HAODONG (US); ADAMS MARK D (US)) [X] 1-12,17-20 * SEQ ID # 1-2; page 3, line 10 - page 4, line 12 *;
 [X]WO9814581  (SCHERING CORP) [X] 1-12,17,18 * SEQ ID # 5-8; page 10, line 19 - line 24 * * page 48, line 33 - page 49, line 30 *;
 [E]WO0009151  (SCHERING CORP) [E] 1-12,17-20 * page 1, line 11 - line 16 * * page 3, line 20 - page 5, line 12 *
 [XDY]  - SOTO H ET AL, "The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, (19980707), vol. 95, no. 14, pages 8205 - 8210, XP002144765 [XD] 1-12,17,18 * the whole document * [Y] 13-16

DOI:   http://dx.doi.org/10.1073/pnas.95.14.8205
 [YD]  - WILLIMANN K ET AL, "The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7", EUROPEAN JOURNAL OF IMMUNOLOGY, (199806), vol. 28, no. 6, pages 2025 - 2034, XP002121901 [YD] 13-16 * section "3. Discussion" *

DOI:   http://dx.doi.org/10.1002/(SICI)1521-4141(199806)28:06<2025::AID-IMMU2025>3.0.CO;2-C
 [X]  - DATABASE WPI, 1, Derwent World Patents Index, vol. 1998, no. 35, Database accession no. 1998-414107, XP002144766 & WO9831809 A 19980723 (SHIONOGI & CO LTD) [X] 1-20 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.